LifeMD Appoints Veteran Healthcare Finance Executive Atul Kavthekar as New CFO; Expands Leadership Team

summarizeSummary

LifeMD announced the departure of its CFO, Marc Benathen, and the immediate appointment of Atul Kavthekar, a seasoned healthcare finance executive, as his successor. The company also promoted Jessica Friedeman to Chief Business Officer and Chris Pisano to Chief Marketing Officer.

check_boxKey Events

• CFO Departure

  Marc Benathen resigned as Chief Financial Officer, effective March 31, 2026, to pursue a new opportunity. He will provide transition services for six to twelve months at a fee of $38,117 per month.

• New CFO Appointment

  Atul Kavthekar was appointed Chief Financial Officer, effective March 16, 2026. He brings nearly three decades of executive leadership and financial expertise spanning provider-side healthcare, retail and specialty pharmacy, and e-commerce.

• Significant Equity Grant for New CFO

  As a material inducement to his employment, Mr. Kavthekar will be granted 675,000 restricted stock units (RSUs), with 337,500 time-based and 337,500 performance-based.

• Leadership Team Expansion

  Jessica Friedeman was promoted to Chief Business Officer and Chris Pisano to Chief Marketing Officer, further strengthening the executive leadership team.

auto_awesomeAnalysis

This filing details significant leadership changes at LifeMD, occurring shortly after the company disclosed a financial restatement and material weaknesses in its internal controls in its recent 10-K. While the departure of CFO Marc Benathen is a notable event, the immediate appointment of Atul Kavthekar, who brings extensive experience in healthcare, M&A, and building scalable financial infrastructure, is a strong positive signal. His substantial RSU grant (valued at approximately $2.75 million, representing about 1.4% of the company's market cap) aligns his incentives with long-term shareholder value. The additional promotions of Jessica Friedeman and Chris Pisano further strengthen the executive team, indicating a proactive effort to address operational and strategic growth following recent financial challenges. Investors should view these changes as a strategic move to stabilize and enhance the company's financial and operational leadership.